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Polypeptides rich in glutamic a id are strong inhibitors purified from isolated nuclei of Xenopus luevis oocytes of casein kinase II. The presence 
of tyrosine in these peptides greatly enhances their inhibitory capacity. Using casein as a substrate, copolyglu:tyr (41) has an Z5,, value of 20 nM, 
250 fold lower than that of polyglutamic acid which is 5 PM. A similar large difference is observed when a synthetic peptide is used as substrate. 
The inhibition of copolyglu:tyr is competitive with casein and can be completely reversed by high ionic strength. The relative inhibitory capacity 
of the polypeptides tested, in descending order, is copolyglu:tyr (4: 1) > copolyglu:tyr (1: 1) > polyglu > copolyglu:phe (4: 1) > copolyglu:ala (64) 
> copolyglu:leu (4:l). The high affinity for tyrosine-containing acid peptides is shared by rat liver and yeast casein kinase II so that it seems to 
be a general property of these. enzymes. 
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1. INTRODUCTION 
Casein kinase II (CK-II) is a messenger-independent 
protein kinase that is present in the cytoplasm and 
nuclear fractions of many cell types (for review see [l]). 
Although the mechanism for the regulation of this en- 
zyme is not known, its activity can be increased 
significantly by treatment of the cells with hormones, 
growth factors or phorbol esters [2,3]. Additional in- 
terest in this enzyme arises from the fact that it has been 
shown to phosphorylate several key proteins involved in 
the replication and transcription of nucleic acids: RNA 
polymerases I and II [4,5], DNA topoisomerase II [a], 
transcription factor S-II [7]. It may also be relevant hat 
several nuclear oncogenes (myc, fos, jun, SV-40 T an- 
tigen, and the adenovirus ElA protein) have amino acid 
sequences that are typical of those phosphorylated by 
CK-II [3,8]. 
sive study of the competitive inhibition of CK-II by syn- 
thetic acidic peptides, as well as by polyaspartic and 
polyglutamic acids [9,12]. However, recent observa- 
tions that some specific nucleic acids are also potent in- 
hibitors of this enzyme while others are not inhibitory 
indicate that the polyanionic character of a polymer is 
not the sole characteristic that determines its affinity 
for the enzyme [13]. 
The groups of Pinna and Krebs have analyzed the se- 
quences phosphorylated by CK-II and have used syn- 
thetic peptides to define the specificity constraints of 
this enzyme [9,10]. These studies have indicated that 
CK-II phosphorylates either serines or threonines that 
are followed, towards the carboxyl end, by a cluster of 
acidic amino acids or by amino acids previously 
phosphorylated by other kinases. 
CK-II is the most abundant protein phosphorylating 
activity present in the nuclei of the oocytes of Xenopus 
laevis [14], and it has been implicated in the process of 
the meiotic maturation of these cells [ 151. In the present 
study we have used CK-II purified from the nuclei of X. 
faevis oocytes to determine the inhibitory effect of 
several synthetic mixed polypeptides containing high 
proportions of glutamic acid. A dramatic increase in 
the inhibitory capacity of these peptides is observed 
when tyrosine is included in their structure. When this 
work was being completed, a very recent publication by 
Meggio and Pinna [16] was brought to our attention. 
These researchers obtained similar results with rat liver 
CK-II. Our work, therefore, confirms and extends their 
observations and indicates that the high affinity for 
copolymers of glutamic acid and tyrosine is a general 
property of CK-II purified from different sources. 
The specificity of this enzyme for polyanionic peptide 
substrates explains its acute sensitivity to heparin in- 
hibition which is competitive with the protein substrate 
[l 11. Pinna and his collaborators have made an exten- 
2. MATERIALS AND METHODS 
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Ovaries were obtained by surgery from adult female X. laevis. 
Stage 5 and 6 oocytes and nuclei were prepared as described by Burzio 
and Koide [17]. Highly purified oocyte CK-II was prepared from 
isolated X. laevis oocyte nuclei by chromatography on DEAE- 
Sephadex [18] and phosphocellulose [14] as described originally by 
Hathaway and Traugh [19]. Yeast CK-II was kindly donated by H. 
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Sternbach (Max Planck Institute). CK-I was purified from oocyte 
nuclear extracts using DEAE-Sephadex chromatography [18]. CAMP 
dependent protein kinase was obtained from Sigma. 
Amino acid polymers and copolymers are denoted by the compo- 
nent amino acid, their molar ratio in parentheses when pertinent, and 
the average relative molecular weight as determined by viscosity and 
reported by the manufacturer. Polymers purchased from Sigma were 
the sodium salts of polyglutamic acid, M, 43,000; polyaspartic acid, 
42,500; copolyglu: tyr (4: I), 46,000; copolyglu: phe (4: l), 16,000; 
copolyglu : leu (4 : l), 10,000; copolyglu :ala (6: 4), 30,000; copoly- 
glu:lys:tyr (6:3: l), 23,000; copolyglu:ala:tyr (6:3: l), 25,000. 
Copolyglu: tyr (1: l), M, 12,500; was prepared and kindly donated by 
Dr. M. Sela (Weizmann Institute). The synthetic oligopeptide used as 
substrate, Arg-Arg-Arg-Glu-Glu-Glu-Thr-Thr-Thr-Glu-Glu-Glu-Glu 
(RRREEETTTEEEE), was kindly donated by Dr. R. Bravo, then at 
EMBL. Polymers and synthetic peptides were dissolved in distilled 
water with the exception of the copolymers copolyglu: phe (4 : 1) and 
copolyglu : leu (4 : 1) which were dissolved in NHdOH at pH 9 and the 
pH readjusted to 7.8 with the assay buffer. 
[y-“P]ATP was prepared by the method of Walseth and Johnson 
[20] using [“PI from Amersham. Dephosphorylated casein used as 
substrate in assays was prepared as described [19]. 
Casein kinase ZZ assay: Reactions (50 ~1) contained 50 mM Hepes, 
pH 7.8; 180 mM KCl, 7 mM MgC12, 0.5 mM dithiothreitol, and 100 
pM [y-‘*P]ATP (500-1000 cpm/pmol). All assays contained 20-30 
units/ml of CK-II [14] and either 5.0 mg/ml dephosphocasein or 3.5 
mM synthetic peptide substrate, as indicated. All additions were made 
prior to the addition of the enzyme. Incubation times were routinely 
15 min at 30°C and the reaction was linear for at least 30 min. The 
reaction was terminated by the removal of an aliquot to a 2x 1 cm 
Whatman P81 phosphocellulose paper which was immersed in 75 mM 
phosphoric acid, washed 3 times in the same acid, dried and counted. 
Values reported have been corrected for controls run with heat- 
denatured enzyme. All assays were performed in duplicate and are 
representative of 2-4 experiments. 
3. RESULTS 
The results presented in Fig. 1 show the inhibition of 
oocyte CK-II by different polypeptides rich in glutamic 
acid. In Fig. lA, the oocyte CK-II is assayed using ca- 
sein as substrate. The enzyme is strongly inhibited by 
micromolar concentrations of all of these polymers. It 
is observed, however, that the introduction of tyrosine 
residues into the copolymer at a ratio of glu : tyr of 4 : 1 
causes a dramatic enhancement of the inhibitory 
capacity. This copolymer is 250 times more efficient as 
an inhibitor when compared to polyglutamic acid of 
similar molecular weight. With a higher percentage of 
tyrosine, as in the copolyglu : tyr (1: l), the enhance- 
ment of inhibition is not as great, being only 4 fold 
more potent than polyglutamic. The presence of 
phenylalanine rather than tyrosine residues as in the 
polymer copolyglu : phe (4: 1) results in an inhibitor 
which is less efficient than both polyglu : tyr (1: 1) and 
polyglutamic acid. The introduction of alanine into a 
copolymer with a ratio of glutamic to alanine of 6:4 
likewise decreases the inhibitory capacity of the polya- 
nion (8 fold below that of polyglutamic). 
It has been previously demonstrated that CK-II can 
use synthetic model peptides as substrates [9,12]. Such 
a peptide, with the sequence Arg-Arg-Arg-Glu-Glu- 
Glu-Thr-Thr-Thr-Glu-Glu-Glu-Glu, has been tested 
with the oocyte CK-II and found to be a substrate with 
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Fig. 1. Inhibition of oocyte nuclear CK-II activity by polymers rich in 
glutamic acid. (A) Assays were carried out using purified CK-II from 
oocyte nuclei as described in Materials and Methods with 5 mg/ml ca- 
sein as substrate in the presence of the sodium salts of polymers of 
average M, as indicated: polyglutamic acid, A4, 43,000 (0); 
copolyglu :ala (6: 4), M, 30,000 (A); copolyglu :phe (4: l), M, 16,000 
(x); copolyglu:tyr (1: l), M, 12,500 (0); copolyglu:tyr (4: l), M, 
46,000 (0). (B) Assays were carried out as in A except with the syn- 
thetic peptide substrate RRREEETTTEEEE at 3.5 mM and in the 
presence of the sodium salts of the polymers: polyglutamic acid, M, 
43,000 (A); copolyglu: tyr (4: l), M, 46,000 (0). 
a K,,, of 0.33 mM (data not shown). In Fig. lB, results 
are presented showing the effect of the copolyglu: tyr 
(4 : 1) and polyglutamic acid on the phosphorylation of 
this synthetic peptide. Again, the inhibitory effect of 
the mixed polymer is more than two orders of 
magnitude greater than that of the homopolymer, with 
Iso of 2 nM and 500 nM, respectively. 
The nature of the inhibition of the copolyglu: tyr 
(4: 1) was studied using casein as substrate. Fig. 2 
demonstrates that the mixed polymer is competitive 
with the substrate casein and has a apparent Ki of 17 
nM. We also observed competitive inhibition by 
polyglutamic acid with an apparent Ki of 3.8 PM (data 
not shown). 
Table I presents the ZSO of these polymers and of 
several others polypeptides analyzed. It can be seen that 
as has been observed with rat liver CK-II [9] the oocyte 
enzyme is more sensitive to polyaspartic acid than to 
polyglutamic acid. It is also evident that the presence of 
a positively charged side chain does not greatly reduce 
the affinity of the copolymer as seen by comparing the 
ZSO values of copolyglu: lys : tyr (6 : 3 : 1) with that of 
copolyglu : ala : tyr (6 : 3 : 1). 
Pure CK-II obtained from yeast was also tested with 
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Fig. 2. Inhibition of oocyte CK-II phosphorylation of casein by 
copolyglu : tyr (4: 1). Casein concentrations used were 2 (o), 4 (0), 6 
(x) and 10 (A) mg/ml in the standard assay system, in the presence 
of varying concentrations of copolyglu :tyr (4: 1). M, 46,000. An ap- 
parent Ki of 0.017 PM was determined. 
polyglutamic acid and copolyglu : tyr (4: 1). The results 
were similar to those obtained with the amphibian en- 
zyme in that the tyrosine-containing polymer was two 
orders of magnitude stronger as inhibitor than 
polyglutamic acid (results not shown). On the other 
hand two other protein kinases, CK-I from X. faevis 
oocyte nuclei [18] with casein as substrate, and com- 
mercial CAMP-dependent protein kinase from rabbit 
muscle with mixed histones as substrate, were tested 
with copolyglu : tyr (4 : 1). Concentrations of this 
copolymer that give complete inhibition of CK-II (3 
PM), did not inhibit these other kinases (results not 
shown). 
CK-II activity is highly dependent on ionic strength 
[ 191, reaching an optimum at 180 mM NaCl under our 
assay conditions. The effect of ionic strength on the 
Table 1 
Inhibition of CK-II by different polyanionic polymers 
Polymer Mr bo 
pg/ml PM 
Polyaspartic acid 42,500 11 0.25 
Polyglutamic acid 43,000 215 5 
Copolyglu : tyr (4 : 1) 46,000 0.9 0.02 
Copolyglu : phe (4 : 1) 16,000 102 6.4 
Copolyglu : leu (4: 1) 10,000 800 80 
Copolyglu : tyr (1 : 1) 12,500 16 1.3 
Copolyglu : ala (6 : 4) 30,000 1200 40 
Copolyglu : ala : tyr (6 : 3 : 1) 25,000 250 10 
Copolyglu : lys : tyr (6 : 3 : 1) 23,000 515 25 
150 is defined as the concentration required to give 50% inhibition of 
the CK-II activity, assayed under standard condition given in 
Materials and Methods. In these assays casein was used as substrate. 
capacity of both polyglutamic acid and copolyglu : tyr 
(4: 1) to inhibit the amphibian CK-II was tested by in- 
creasing concentrations of NaCl. With both polymers 
inhibition is reverted by high salt. As seen in Fig. 3, 
levels of polymers which give 60% inhibition at or 
below optimal salt concentrations are not inhibitory 
over 250 mm NaCl. 
4. DISCUSSION 
The results presented above demonstrate that the 
presence of tyrosine in glutamic acid-rich random 
copolymers greatly increases the inhibitory capacity of 
these polymers towards oocyte CK-II. The copolymer 
polyglu:tyr (4: 1) has an ZSO of 22 nM, and is approx- 
imately 250-fold more efficient than polyglutamic acid. 
The relative efficiency of these two polymers as in- 
hibitors is the same for the phosphorylation of the pro- 
tein substrate casein and a specific synthetic peptide 
substrate. 
The finding that the inhibition caused by both 
polyglutamic and copolyglutyr is competitive with the 
substrate probably explains the finding that the concen- 
tration of either inhibitory copolymer required for 50% 
inhibition with the synthetic peptide substrate is one 
order of magnitude lower than that observed when ca- 
sein is used as substrate. Synthetic peptides have been 
shown previously to have higher apparent K,,, values as 
compared to protein substrates for CK-II [12]. 
Two additional copolymers of glu : X (4 : 1) ratio were 
tested and it was seen that the substitution of phenyl- 
alanine or leucine for the tyrosine moiety greatly reduc- 
ed the inhibitory capacity of the polyanion. In order to 
obtain a closer approximation of the relative effective- 
ness of these three compounds as inhibitors, indepen- 
dent of the degree of polymerization of the polypep- 
tides which is known to affect the affinity for the en- 
zyme [12], the ZOO values were calculated on the basis of 
the monomer unit, glu4:Xr. (The difference in the 
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Fig. 3. Reversal of inhibition of oocyte CK-II activity by 
polyglutamic acid and copolyglu :tyr (4 : 1) at increasing salt concen- 
trations. Polymer concentrations used were those required to give 
60% inhibition of CK-II in the standard assay system (at 180 mM 
NaCl) and were 35 nM for copolyglu: tyr (4: 1) (0) and 8.5 PM for 
polyglutamic acid (0). Enzyme activity was then determined in the 
presence and absence of the polymers at each salt concentration. 
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monomer molecular weight due to the contribution of 
the varied amino acid is minimal.) On this basis, the 
midpoints of inhibition for the three copolymers 
glu : tyr, glu: phe, and glu : leu are 1.3, 153 and 1263pM, 
respectively, clearly demonstrating the notable effect of 
the tyrosine residue. The relative amount as well as the 
nature of the nonpolar amino acid in the polypeptides 
appears to be important in determining their inhibitory 
efficiency. Copolyglu : tyr (1: 1) is less effective than the 
4 : 1 copolymer of the same composition. 
The fact that copolyglu : tyr (4 : 1) is also a stronger in- 
hibitor of yeast CK-II than polyglutamic acid and a 
previous similar observation with the rat liver CK-II 
[ 161 indicate that the effect of tyrosine on the affinity is 
a general property of CK-II. However, the finding that 
this same polymer under similar conditions does not in- 
hibit oocyte CK-I or rabbit CAMP-dependent protein 
kinase demonstrates that this phenomenon does not 
apply to all other protein kinases. 
The observation that the introduction of tyrosine or 
other nonpolar amino acids into polyglutamic acid 
copolymers greatly enhances the inhibitory capacity of 
these polyanionic molecules was made by Sela and his 
collaborators more than 25 years ago, when a similar 
phenomenon was described for the inhibition of 
ribonuclease, trypsin and lysozyme by polyglutamic 
acid and copolymers rich in this amino acid [21,22]. 
These authors interpreted their results by postulating 
that the large aromatic or aliphatic hydrophobic side 
chains of tyrosine, phenylalanine or leucine interspers- 
ed among the negative charges of the glutamic acid 
residues could greatly favor the interaction of these 
polymers with many basic enzymes, and that both elec- 
trostatic and hydrophobic forces are important in the 
inhibitory process. In the present case, there seems to 
exist an additional factor related to the specificity of the 
active site of CK-II since tyrosine residues are clearly 
different from phenylalanine and leucine in their poten- 
tiation of the inhibition of this enzyme by polyanionic 
peptides. However, electrostatic properties of these 
polyanions indeed must play a role in their interaction 
with the enzyme since high ionic strength can complete- 
ly reverse their effect. 
The fact that copolymers of glutamic acid and 
tyrosine are very potent inhibitors of CK-II is very sug- 
gestive in view of the fact that these same copolymers 
are substrates of tyrosine kinaseas [23]. In fact, of the 
synthetic tyrosine polymers tested as substrates for in- 
sulin receptor kinase the most efficient was found to be 
copolyglu : tyr (4 : 1) [23]. The best characterized 
tyrosine kinases are the membrane-bound enzymes that 
are involved in transducing external mitogenic signals. 
Many of the membrane-located proteins that are pro- 
ducts of oncogenes have tyrosine kinase activity, but 
the identity of the substrates that they phosphorylate 
and that are responsible for relaying the proliferative 
signal to the nucleus has remained elusive. It seems 
116 
possible, therefore, that proteins containing tyrosines 
imbedded in highly acid sequences may provide a link 
between the membrane-bound tyrosine kinases and 
nuclear protein kinases which, like CK-II, may be in- 
volved in phosphorylating nuclear oncogenes. It would 
be of considerable interest to determine whether 
phosphorylation of the tyrosine residues present in 
copolyglu: tyr peptides or in natural proteins with 
similar sequences influences their affinity for CK-II. 
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